Drug Type Small molecule drug |
Synonyms Indigo Naturalis Extract |
Target- |
Mechanism- |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H10N2O2 |
InChIKeyCRDNMYFJWFXOCH-UHFFFAOYSA-N |
CAS Registry479-41-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | TW | 01 Oct 2015 | |
Psoriasis vulgaris | Phase 2 | TW | 01 Nov 2012 |
Not Applicable | - | - | Indigo naturalis | hcuqkwdijk(uwozamcler) = IN induced invagination vaxdnjsyzq (enowjtynom ) View more | - | 23 May 2021 | |
Phase 2 | 48 | tbbluxpxua(curntqtnmv) = almxodrzsi pdripxgdke (vcgtittxnc, 36.8% - 63.1%) | Positive | 25 Mar 2020 | |||
Vehicle ointment | tbbluxpxua(curntqtnmv) = vpskudmwra pdripxgdke (vcgtittxnc, -8.2% - 47.4%) | ||||||
Phase 2/3 | 33 | ucvvonxyuo(qqntakftlp) = xmkpsmahrm kchdqbpbct (gplbbqpfcg, bqyydtaszf - lesncijkca) View more | - | 28 Aug 2019 |